G Protein News and Research

RSS

INTEGRA’s new video demonstrates benefits of VIAFLO 96/384 microplate pipettes

INTEGRA continues to place itself at the forefront of pipetting technology, developing and perfecting its VIAFLO 96/384 range of microplate pipettes for a variety of applications, including ELISA, PCR, and nucleic acid and protein extraction.

From INTEGRA Biosciences 30 Sep 2017

BSACI’s new guidelines enhance diagnosis and management of peanut allergy

A new guideline published recently by the Standards of Care Committee of the British Society for Allergy & Clinical Immunology (BSACI) aims to bring together the latest science in order to improve the diagnosis and management of peanut and tree nut allergy.

30 Sep 2017

British technology offers ultimate surface protection against Aussie flu virus

With breaking news of a more severe Aussie Flu strain heading for the UK, there is a British technology that provides the ultimate surface protection against the virus - reducing it by 99.99%!

30 Sep 2017

Revolutionary skin treatment offers hope to acid attack victims, burns patients

The horrific increase in the number of acid attacks in the UK has given medical research trust RAFT even more reason to back its latest next generation artificial skin called Smart Matrix which was specially invented to help burns victims.

30 Sep 2017

TSRI scientists developed new strategy to discover novel anti-cancer therapies

Scientists at The Scripps Research Institute (TSRI) have developed and demonstrated a promising new strategy for the discovery of novel anti-cancer therapies.

30 Sep 2017

Biochemists discover genes that determine animal complexity

Genes which determine animal complexity – or what makes humans so much more complex than a fruit fly or a sea urchin – have been identified for the first time.

30 Sep 2017

Scientists explore the reason behind impaired sense of smell in Parkinson's disease

The first symptom of Parkinson's disease is often an impaired sense of smell. This neurodegenerative disease primarily causes irreparable damage to nerve cells in a brain area involved in movement control.

30 Sep 2017

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."

28 Sep 2017

Chromatrap ChIP-Seq kits can deliver streamlined protocol from nanograms of starting material

Chromatrap has demonstrated that its unique solid state patented technology allows for ChIP-seq assays to be routinely performed from as little as 500 ng of chromatin.

From Chromatrap® - Porvair Sciences Ltd 28 Sep 2017

Research reveals novel mechanism of ribosome dimerization using cryo-electron microscopy

Antibiotics are the most common medication used to treat microbial infections. Many antibiotics target intracellular bacterial ribosomes - cellular factories that synthesize proteins - which are essential for bacterial survival and proliferation.

28 Sep 2017

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors.

28 Sep 2017

NIH awards $1.5 million grant to support education in Alzheimer's disease at RPI

We know Alzheimer's as a brutal disease that dismantles our loved ones and condemns them to death. But science and engineering researchers look inside the disease to identify early warning signs and develop the imaging techniques to see them, to unravel the biochemical puzzle that creates a toxic clump of misfolded proteins, and to develop and test new drugs and therapies that chip away at cognitive decline.

28 Sep 2017

New paper-based test can diagnose Zika infection within 20 minutes

MIT researchers have developed a paper-based test that can diagnose Zika infection within 20 minutes. Unlike existing tests, the new diagnostic does not cross-react with Dengue virus, a close relative of the Zika virus that can produce false positives on many Zika tests.

27 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Previous
1
...
7
8
9
10
11
12
13
...
1306
Next

G Protein News and Research

INTEGRA’s new video demonstrates benefits of VIAFLO 96/384 microplate pipettes

BSACI’s new guidelines enhance diagnosis and management of peanut allergy

British technology offers ultimate surface protection against Aussie flu virus

Revolutionary skin treatment offers hope to acid attack victims, burns patients

TSRI scientists developed new strategy to discover novel anti-cancer therapies

Biochemists discover genes that determine animal complexity

Scientists explore the reason behind impaired sense of smell in Parkinson's disease

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Chromatrap ChIP-Seq kits can deliver streamlined protocol from nanograms of starting material

Research reveals novel mechanism of ribosome dimerization using cryo-electron microscopy

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

NIH awards $1.5 million grant to support education in Alzheimer's disease at RPI

New paper-based test can diagnose Zika infection within 20 minutes

High-speed method generates mini-protein binders with potential to become new class of drugs

Understanding molecular mechanisms and metabolic pathways of yeast for drug discovery

Researchers reveal reason for olfactory dysfunction in initial stage of Alzheimer's disease

Adding, removing water from a stem cell can determine its role as bone or fat

Huddersfield cancer scientists aim to develop new treatments for young people

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Drug combination produces synergistic effect against growth of triple-negative breast cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News